Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-08-14 | Jerome Zeldis, MD, PhD has been a director since June 2011. The Compensation Committee is comprised of Dr. Rubin (Chair), Mr. Brownlie and Dr. Zeldis. The Nominating and Corporate Governance Committee is comprised of Dr. Zeldis (Chair), Mr. Brownlie and Mr. Lapointe. The following table contains information concerning the compensation of the non-employee directors during the fiscal year ended December 31, 2012. Jerry Zeldis received $47,500 in fees and $7,500 in option awards, totaling $55,500. |
| 2014-05-08 | Jerome Zeldis, MD, PhD has been a director since June 2011... The Board of Directors has the following three committees: (1) Compensation, (2) Audit and (3) Nominating and Corporate Governance... Jerome Zeldis - Compensation Committee, Nominating and Corporate Governance Committee (Chair)... Compensation of Directors: Jerry Zeldis - Fees Earned Paid in Cash $50,000, Option Awards $30,000, Total $80,000. |
| 2015-05-01 | Jerome Zeldis, MD, PhD has been a director since June 2011. Dr. Zeldis was selected to serve as a member of our Board of Directors because of his experience as an executive officer of a publicly traded biopharmaceutical company... The Compensation Committee is comprised of Dr. Rubin (Chair), Dr. Brughera and Dr. Zeldis. |
Data sourced from SEC filings. Last updated: 2025-12-07